Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maadh Aldouri

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Pathophysiology of Haemostasis and Thrombosis|September 6, 2002
The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patientsMaadh Aldouri
Acta Paediatrica (Oslo, Norway : 1992)|August 12, 2005
Anti-C(w) alloimmunization presenting as hydrops fetalisTanoj Gopalam Kollamparambil, Bhavdeep Rameshchandra Jani, Maadh Aldouri, et al.
European Journal of Cancer Care|April 28, 2011
Relapsed multiple myeloma in the UK prior to the introduction of novel agents--a response to Koleva et al. (2010)John Quinn, Fran Percival, Martin Auger, et al.
The Lancet. Haematology|May 1, 2019
Effect of low-level BCR-ABL1 kinase domain mutations identified by next-generation sequencing in patients with chronic myeloid leukaemia: a population-based studyAytug Kizilors, Elena Crisà, Nicholas Lea, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Pathophysiology of Haemostasis and Thrombosis|September 6, 2002
The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patientsMaadh Aldouri
Acta Paediatrica (Oslo, Norway : 1992)|August 12, 2005
Anti-C(w) alloimmunization presenting as hydrops fetalisTanoj Gopalam Kollamparambil, Bhavdeep Rameshchandra Jani, Maadh Aldouri, et al.
European Journal of Cancer Care|April 28, 2011
Relapsed multiple myeloma in the UK prior to the introduction of novel agents--a response to Koleva et al. (2010)John Quinn, Fran Percival, Martin Auger, et al.
The Lancet. Haematology|May 1, 2019
Effect of low-level BCR-ABL1 kinase domain mutations identified by next-generation sequencing in patients with chronic myeloid leukaemia: a population-based studyAytug Kizilors, Elena Crisà, Nicholas Lea, et al.
Pageof 1